Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
43.1M
-
Number of holders
-
36
-
Total 13F shares, excl. options
-
23.9M
-
Shares change
-
+854K
-
Total reported value, excl. options
-
$735M
-
Value change
-
+$26M
-
Number of buys
-
18
-
Number of sells
-
-26
-
Price
-
$30.77
Significant Holders of Repare Therapeutics Inc. - Common Shares, no par value (RPTX) as of Q3 2020
56 filings reported holding RPTX - Repare Therapeutics Inc. - Common Shares, no par value as of Q3 2020.
Repare Therapeutics Inc. - Common Shares, no par value (RPTX) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23.9M shares
of 43.1M outstanding shares and own 55.45% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (3.43M shares), BVF INC/IL (3.06M shares), MPM ASSET MANAGEMENT LLC (3M shares), FMR LLC (2.76M shares), CHI Advisors LLC (2.53M shares), Redmile Group, LLC (2.4M shares), MPM ONCOLOGY IMPACT MANAGEMENT LP (2.39M shares), Logos Global Management LP (977K shares), Artal Group S.A. (570K shares), and FRANKLIN RESOURCES INC (503K shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.